Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$322M |
| 2 |
UnitedHealth
UNH
|
+$233M |
| 3 |
Microsoft
MSFT
|
+$198M |
| 4 |
International Flavors & Fragrances
IFF
|
+$171M |
| 5 |
Principal Financial Group
PFG
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$714M |
| 2 |
IBM
IBM
|
+$395M |
| 3 |
Cisco
CSCO
|
+$303M |
| 4 |
Procter & Gamble
PG
|
+$290M |
| 5 |
Macy's
M
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.98% |
| 2 | Financials | 14.9% |
| 3 | Healthcare | 12.91% |
| 4 | Industrials | 10.1% |
| 5 | Consumer Discretionary | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Dawson Geophysical
DWSN
$136M
| $1.31M | ﹤0.01% |
170,728
+13,042
| +8% | +$93.9K |
|
|
SALM
3027
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
| $1.31M | ﹤0.01% |
209,256
+98,865
| +90% | +$586K |
|
|
LUMO
3028
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $1.3M | ﹤0.01% |
14,103
-2,214
| -14% | -$249K |
|
3029
Global Water Resources
GWRS
$219M
| $1.3M | ﹤0.01% |
143,264
+96,718
| +208% | +$790K |
|
3030
Malibu Boats
MBUU
$576M
| $1.3M | ﹤0.01% |
68,289
-48
| -0.1% | -$808 |
|
|
CIO
3031
DELISTED
City Office REIT
CIO
| $1.29M | ﹤0.01% |
98,276
+8,691
| +10% | +$109K |
|
|
BLCM
3032
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $1.29M | ﹤0.01% |
9,500
+861
| +10% | +$153K |
|
|
CFMS
3033
DELISTED
Conformis, Inc. Common Stock
CFMS
| $1.29M | ﹤0.01% |
6,391
+706
| +12% | +$156K |
|
|
ADXS
3034
DELISTED
Advaxis Inc
ADXS
| $1.29M | ﹤0.01% |
12,022
-2,691
| -18% | -$363K |
|
3035
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $1.29M | ﹤0.01% |
21,736
+4,009
| +23% | +$247K |
|
3036
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.14B
| $1.28M | ﹤0.01% |
+25,705
| New | +$1.29M |
|
3037
Mizuho Financial
MFG
$134B
| $1.28M | ﹤0.01% |
355,912
+12,255
| +4% | +$42.7K |
|
|
DALN
3038
DELISTED
DallasNews
DALN
| $1.27M | ﹤0.01% |
49,869
+8,006
| +19% | +$208K |
|
|
QUNR
3039
DELISTED
Qunar Cayman Islands Limited
QUNR
| $1.26M | ﹤0.01% |
41,831
-5,891
| -12% | -$175K |
|
|
AXAS
3040
DELISTED
Abraxas Petroleum Corp
AXAS
| $1.26M | ﹤0.01% |
24,435
+3,336
| +16% | +$131K |
|
|
LJPC
3041
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $1.25M | ﹤0.01% |
71,561
+3,233
| +5% | +$62K |
|
3042
Standard BioTools
LAB
$312M
| $1.25M | ﹤0.01% |
171,402
-20,181
| -11% | -$127K |
|
|
BCS.PRA.CL
3043
DELISTED
Barclays Bank Plc Series 3
BCS.PRA.CL
| $1.25M | ﹤0.01% |
49,158
+5,879
| +14% | +$150K |
|
|
CACB
3044
DELISTED
Cascade Bancorp
CACB
| $1.25M | ﹤0.01% |
153,367
+41,786
| +37% | +$290K |
|
3045
DHT Holdings
DHT
$3.09B
| $1.24M | ﹤0.01% |
299,851
+50,671
| +20% | +$201K |
|
3046
Global Industrial
GIC
$1.49B
| $1.24M | ﹤0.01% |
141,414
+102,862
| +267% | +$862K |
|
|
RSO
3047
DELISTED
Resource Capital Corp.
RSO
| $1.24M | ﹤0.01% |
148,506
+28,349
| +24% | +$294K |
|
3048
Nomura Holdings
NMR
$29B
| $1.24M | ﹤0.01% |
209,413
-19,338
| -8% | -$103K |
|
3049
Digimarc Corp
DMRC
$167M
| $1.24M | ﹤0.01% |
41,176
+691
| +2% | +$21.6K |
|
3050
National Bankshares
NKSH
$271M
| $1.24M | ﹤0.01% |
28,420
+3,584
| +14% | +$135K |
|
Similar funds
Bank of New York Mellon's Q4 2016 Portfolio in Review
As of Q4 2016, Bank of New York Mellon held 4,430 positions worth $347B, up 3.3% from $336B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Bank of New York Mellon's Q4 2016 filing shows 161 new, 2,590 increased, 1,402 reduced and 170 closed positions. Its largest new stake was Lamb Weston: 2,449,932 shares worth $92.7M. The largest sale was Merck, an estimated $714M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q4 2016 buy was Lamb Weston: 2,449,932 shares worth $92.7M.
- Bank of New York Mellon added most to CME Group in Q4 2016, an estimated $322M increase.
- Bank of New York Mellon's biggest Q4 2016 reduction was Merck, cutting an estimated $714M.
- Bank of New York Mellon fully exited LinkedIn Corporation in Q4 2016, selling an estimated $82.8M.
- Bank of New York Mellon's ten largest holdings make up 13% of its $347B portfolio in Q4 2016.
- Bank of New York Mellon opened 161 new positions and closed 170 in Q4 2016.
- Bank of New York Mellon's portfolio value rose 3.3% quarter-over-quarter to $347B.
Based on Bank of New York Mellon's 13F filing for Q4 2016, filed 13 Feb 2017.